Results 21 to 30 of about 6,549 (182)

Combining Immunotherapy with Transarterial Radioembolization

Indian Journal of Nuclear Medicine, 2023
Hepatocellular carcinoma (HCC) has a high mortality rate due to the diagnosis of patients at advanced stages and ineffective systemic therapies. Immunotherapy is considered a new treatment option for unresectable HCC alternatives to the limitations of conventional cytotoxic chemotherapy. In this case report, we
Balaban Genc, Zeynep Ceren, Soydemır, Efe, Ersoy, Seval Ay, Ones, Tunc   +3 more
openaire   +3 more sources

Dose finding study for unilobar radioembolization using holmium-166 microspheres to improve resectability in patients with HCC: the RALLY protocol

BMC Cancer, 2023
Background High dose unilobar radioembolization (also termed ‘radiation lobectomy’)—the transarterial unilobar infusion of radioactive microspheres as a means of controlling tumour growth while concomitantly inducing future liver remnant hypertrophy—has ...
Daan Andel, Marnix G. E. H. Lam, Joep de Bruijne, Maarten L. J. Smits, Arthur J. A. T. Braat, Adriaan Moelker, Erik Vegt, Simeon J. S. Ruiter, Walter Noordzij, Gianluca Grazi, Giulio E. Vallati, Roel J. Bennink, Otto M. van Delden, Onno W. Kranenburg, Jan N. M. Ijzermans, Maarten W. Nijkamp, Joris I. Erdmann, Rosa Sciuto, Jeroen Hagendoorn, Inne H. M. Borel Rinkes   +19 more
doaj   +1 more source

Radiation segmentectomy for hepatic malignancies: Indications, devices, dosimetry, procedure, clinical outcomes, and toxicity of yttrium-90 microspheres

Journal of Interventional Medicine, 2019
Radiation segmentectomy (RS) is a new approach to 90Y radioembolization that has been designed to increase the safety and efficacy of radioembolization in patients with unresectable hepatic malignancies.
Zhongzhi Jia, Caoye Wang, Ricardo Paz-Fumagalli, Weiping Wang   +3 more
doaj   +1 more source

Radioembolization Is a Safe and Effective Treatment for Hepatocellular Carcinoma with Portal Vein Thrombosis: A Propensity Score Analysis.

PLoS ONE, 2016
Background/aimsLimited treatment options are available for patients with hepatocellular carcinoma (HCC) with portal vein thrombosis (PVT). Transarterial radioembolization using Yttrium-90 microspheres is a new treatment modality for HCC with PVT.
Young Youn Cho, Minjong Lee, Hyo-Cheol Kim, Jin Wook Chung, Yun Hwan Kim, Geum-Youn Gwak, Si Hyun Bae, Do Young Kim, Jeong Heo, Yoon Jun Kim   +9 more
doaj   +1 more source

Beyond hepatocellular carcinoma and colorectal metastasis: The expanding applications of radioembolization

Frontiers in Oncology, 2014
As a relatively safe outpatient procedure, radioembolization can potentially be used to treat any type of tumor within the liver, primary or metastatic. The safety and effectiveness of radioembolization in the treatment of hepatocellular carcinoma (HCC)
Omar eZurkiya, Suvranu eGanguli
doaj   +1 more source

Bridging treatment prior to liver transplantation for hepatocellular carcinoma: radioembolization or transarterial chemoembolization?

European Journal of Medical Research, 2022
Background In hepatocellular carcinoma (HCC) patients, intraarterial therapies are regularly employed as a bridge to liver transplantation to prevent tumor progression during waiting time. Objective of this study was to compare HCC recurrence after liver
Tamás Benkö, Julia König, Jens M. Theysohn, Clemens Schotten, Fuat H. Saner, Jürgen Treckmann, Sonia Radunz   +6 more
doaj   +1 more source

A single-center experience in radioembolization as salvage therapy of hepatic metastases of uveal melanoma

Acta Radiologica Open, 2015
Background Overall survival (OS) of patients with hepatic metastases of uveal melanoma is strongly linked with hepatic tumor control. Due to the lack of an effective systemic chemotherapy, locoregional therapies like radioembolization should play an ...
Juliane Schelhorn, Heike Richly, Marcus Ruhlmann, Thomas C Lauenstein, Jens M Theysohn   +4 more
doaj   +1 more source

Side Effects of Yttrium-90 Radioembolization

Frontiers in Oncology, 2014
Limited therapeutic options are available for hepatic malignancies. Image guided targeted therapies have established their role in management of primary and secondary hepatic malignancies.
Ahsun eRiaz, Rafia eAwais, Riad eSalem
doaj   +1 more source

Surgery and radioembolization of liver tumors

Revista Española de Medicina Nuclear e Imagen Molecular (English Edition), 2023
Surgical resection is considered the curative treatment par excellence for patients with primary or metastatic liver tumors. However, less than 40% of them are candidates for surgery, either due to non-modifiable factors (comorbidities, age, liver dysfunction…), or to the invasion or proximity of the tumor to the main vascular requirements, the lack of
Rotellar, F. (Fernando), Sancho, L. (Lidia), Batidas, J.F. (Juan Fernando), Martinez-de-la-Cuesta, A. (Antonio), Rodriguez-Fraile, M. (Macarena), Aliseda, D. (Daniel)   +5 more
openaire   +3 more sources

Celiac Artery Stenting to Facilitate Hepatic Yttrium-90 Radioembolization Therapy

Case Reports in Radiology, 2012
Radioembolization offers a novel way to treat the nonresectable, liver predominant hepatic malignancies with better tumor response and overall progression-free survival rates.
Murthy R. Chamarthy, Terence W. Hughes, Mohit Gupta, Josephina A. Vossen, Noel B. Velasco, Kenneth M. Zinn   +5 more
doaj   +1 more source